VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
130 hedge funds and large institutions have $83.3M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less capital invested
Capital invested by funds: $191M → $83.3M (-$108M)
Holders
130
Holding in Top 10
–
Calls
$407K
Puts
$99K
Top Buyers
| 1 | +$978K | |
| 2 | +$499K | |
| 3 | +$446K | |
| 4 |
BlackRock
New York
|
+$393K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$316K |
Top Sellers
| 1 | -$9.89M | |
| 2 | -$919K | |
| 3 | -$843K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$550K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$434K |